Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 89


Peripartum management of dual antiplatelet therapy and neuraxial labor analgesia after bare metal stent insertion for acute myocardial infarction.

Bauer ME, Bauer ST, Rabbani AB, Mhyre JM.

Anesth Analg. 2012 Sep;115(3):613-5. doi: 10.1213/ANE.0b013e31825ab374. Epub 2012 May 14. Erratum in: Anesth Analg. 2012 Dec;115(6):1430.


Left main stent thrombosis complicated by eptifibatide-induced acute thrombocytopenia.

Yang EH, Perez E, Zhiroff KA, Burstein S.

Tex Heart Inst J. 2011;38(2):174-8.


Prolonged clopidogrel use after bare metal and drug-eluting stent placement: the Veterans Administration drug-eluting stent study.

Faxon DP, Lawler E, Young M, Gaziano M, Kinlay S.

Circ Cardiovasc Interv. 2012 Jun;5(3):372-80. doi: 10.1161/CIRCINTERVENTIONS.111.967257. Epub 2012 Jun 5.


Frequency and predictors of stent thrombosis after percutaneous coronary intervention in acute myocardial infarction.

Dangas GD, Caixeta A, Mehran R, Parise H, Lansky AJ, Cristea E, Brodie BR, Witzenbichler B, Guagliumi G, Peruga JZ, Dudek D, Möeckel M, Stone GW; Harmonizing Outcomes With Revascularization and Stents in Acute Myocardial Infarction (HORIZONS-AMI) Trial Investigators.

Circulation. 2011 Apr 26;123(16):1745-56. doi: 10.1161/CIRCULATIONAHA.110.981688. Epub 2011 Apr 11.


Primary percutaneous coronary angioplasty with and without eptifibatide in ST-segment elevation myocardial infarction: a safety and efficacy study of integrilin-facilitated versus primary percutaneous coronary intervention in ST-segment elevation myocardial infarction (ASSIST).

Le May MR, Wells GA, Glover CA, So DY, Froeschl M, Marquis JF, O'Brien ER, Turek M, Thomas A, Kass M, Jadhav S, Labinaz M.

Circ Cardiovasc Interv. 2009 Aug;2(4):330-8. doi: 10.1161/CIRCINTERVENTIONS.108.847582.108.847582. Epub 2009 Jul 22.


Prolonged infusion of eptifibatide as bridge therapy between bare-metal stent insertion and cardiovascular surgery: case report and review of the literature.

Pickett AM, Taylor DA, Ackman ML.

Pharmacotherapy. 2010 Apr;30(4):127e-33e. doi: 10.1592/phco.30.4.420. Review.


Stent thrombosis, clinical events, and influence of prolonged clopidogrel use after placement of drug-eluting stent data from an observational cohort study of drug-eluting versus bare-metal stents.

Park DW, Yun SC, Lee SW, Kim YH, Lee CW, Hong MK, Cheong SS, Kim JJ, Park SW, Park SJ.

JACC Cardiovasc Interv. 2008 Oct;1(5):494-503. doi: 10.1016/j.jcin.2008.06.011.


Three-month dual antiplatelet therapy after implantation of zotarolimus-eluting stents: the DATE (Duration of Dual Antiplatelet Therapy AfterImplantation of Endeavor Stent) registry.

Hahn JY, Song YB, Choi JH, Choi SH, Lee SY, Park HS, Hur SH, Lee S, Han KR, Rha SW, Cho BR, Park JS, Yoon J, Lim DS, Lee SH, Gwon HC; DATE Registry Investigators.

Circ J. 2010 Nov;74(11):2314-21. Epub 2010 Oct 2.


Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).

Valgimigli M, Tebaldi M, Borghesi M, Vranckx P, Campo G, Tumscitz C, Cangiano E, Minarelli M, Scalone A, Cavazza C, Marchesini J, Parrinello G; PRODIGY Investigators.

JACC Cardiovasc Interv. 2014 Jan;7(1):20-8. doi: 10.1016/j.jcin.2013.09.008. Epub 2013 Dec 11.


Safety and efficacy of ticlopidine for only 2 weeks after successful intracoronary stent placement.

Berger PB, Bell MR, Hasdai D, Grill DE, Melby S, Holmes DR Jr.

Circulation. 1999 Jan 19;99(2):248-53.


Evaluating the safety of very short-term (10 days) dual antiplatelet therapy after Genous™ bio-engineered R stent™ implantation: the multicentre pilot Genous trial.

Sangiorgi GM, Morice MC, Bramucci E, Ferlini M, Grinfeld L, Petronio AS, Pierli C, Iadanza A, Biondi-Zoccai G, Colombo A.

EuroIntervention. 2011 Nov;7(7):813-9. doi: 10.4244/EIJV7I7A128.


[Perioperative antiplatelet therapy of patients with coronary stents].

Chatterjee T, Akin I, Rehders TC, Chatterjee A, Schüpfer C, Nienaber CA, Ince H.

Praxis (Bern 1994). 2009 Oct 21;98(21):1199-210. doi: 10.1024/1661-8157.98.21.1199. Review. German.


Bivalirudin and clopidogrel with and without eptifibatide for elective stenting: effects on platelet function, thrombelastographic indexes, and their relation to periprocedural infarction results of the CLEAR PLATELETS-2 (Clopidogrel with Eptifibatide to Arrest the Reactivity of Platelets) study.

Gurbel PA, Bliden KP, Saucedo JF, Suarez TA, DiChiara J, Antonino MJ, Mahla E, Singla A, Herzog WR, Bassi AK, Hennebry TA, Gesheff TB, Tantry US.

J Am Coll Cardiol. 2009 Feb 24;53(8):648-57. doi: 10.1016/j.jacc.2008.10.045.


Drug-eluting stent thrombosis 1,659 days after stent deployment: case report and literature review.

Al-Dehneh A, Virk H, Alkhouri Y, Hamdan A, Bikkina M.

Tex Heart Inst J. 2010;37(3):343-6. Review.

Supplemental Content

Support Center